Clinical value of soluble urokinase-type plasminogen activator receptor in predicting sepsis-associated acute kidney injury

Wenwen Zhang,Yue Gu,Jing Zhou,Juntao Wang,Xiaoru Zhao,Xiaoyu Deng,Han Li,Lei Yan,Xiaojing Jiao,Fengmin Shao
DOI: https://doi.org/10.1080/0886022x.2024.2307959
IF: 3.222
2024-02-01
Renal Failure
Abstract:Background Sepsis-associated acute kidney injury (S-AKI) is a critical illness and is often associated with high morbidity and mortality rates. The soluble urokinase-type plasminogen activator receptor (suPAR) is an important immune mediator and is involved in kidney injury. However, its diagnostic value in S-AKI patients remains unclear. Therefore, we assessed the early predictive value of suPAR for S-AKI patients.
urology & nephrology
What problem does this paper attempt to address?